XML 29 R21.htm IDEA: XBRL DOCUMENT v3.23.1
Medical Oncology Partners (Details) - USD ($)
3 Months Ended
Dec. 31, 2022
Dec. 31, 2016
Mar. 31, 2023
Mar. 31, 2022
Dec. 23, 2016
Medical Oncology Partners [Abstract]          
Carrying value of investment $ 157,000   $ 137,000    
USNC's equity in (loss) income     $ 3,000 $ (133,000)  
USNC [Member]          
Medical Oncology Partners [Abstract]          
Proceeds from sale of assets 2,060,000        
Payment for management fees $ 1,300,000        
MOP [Member]          
Medical Oncology Partners [Abstract]          
Equity interest percentage to be acquired by subsidiary     100.00%    
Investments in unconsolidated entities     $ 450,000    
USNC's equity in (loss) income   $ (12,000)      
MOP [Member] | Other Investor [Member]          
Medical Oncology Partners [Abstract]          
Investments in unconsolidated entities     105,000    
MOP [Member] | USNC [Member]          
Medical Oncology Partners [Abstract]          
Investments in unconsolidated entities     173,000    
Ownership percentage         35.83%
Carrying value of investment     149,000   $ 161,000
MOP [Member] | USNC [Member] | Dr. Jaime Lozano [Member]          
Medical Oncology Partners [Abstract]          
Investments in unconsolidated entities     $ 345,000    
Ownership percentage     76.67%    
Percentage of equity interest to an additional investor as a consulting fee for services     5.00%